Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Should Sponsors Provide Source Document Templates?
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. read more
Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
Executive Q&A - Early Drug Development
In this Q&A, we explore early-stage pharmaceutical drug development trends, key scientific and technical challenges, and the role emerging technologies play in enhancing efficiency and quality during early pharmaceutical development. read more
Prefilled Syringes: Sterile Drug Delivery, Market Dynamics, CDMO Partnerships, and Market Outlook to 2030
The global pharmaceutical sterile and prefilled syringe market has experienced remarkable growth in recent years, fueled by technological advances and evolving therapeutic needs. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Avid Bioservices Appoints Chief Commercial Officer
Tuesday, May 12, 2026
Avid Bioservices announced the appointment of Kerri McCullough Wood as Chief Commercial Officer. read more
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
Tuesday, May 12, 2026
Ardena announced the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further ... read more
GI Partners Completes Acquisition of the CDMO and Cell Solutions Businesses from Charles River Laboratories and forms Rose BioSolutions
Tuesday, May 12, 2026
GI Partners, a private investment firm, announced it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) ... read more
Symeres Appoints Steinhagen as CEO to Drive Next Phase Of Strategic Growth
Tuesday, May 12, 2026
Symeres announced the appointment of Henning Steinhagen as Chief Executive Officer, marking a key transition as the company scales its operations and ... read more
Hovione Announces Leadership Transition and Interim Co-CEO Structure
Tuesday, May 12, 2026
Hovione announced that Dr. Jean Luc Herbeaux has decided to step down from his role as Chief Executive Officer for personal reasons, effective as of ... read more